Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > Sihuan Roxatidine Wins Production Approval

FDAnews Drug Daily Bulletin

Nov. 2, 2012 | Vol. 9 No. 216

Sihuan Roxatidine Wins Production Approval

Sihuan Pharmaceutical Holdings has received a new drug certificate and production approval for Roxatidine Acetate Hydrochloride for injection.
Pharmaceutical Business Review

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Full Issue New Information Chiefs to Restructure FDA IT Office FDA: Merck’s Insomnia Drug Effective But Dosage Should Be Dialed Down California Senate Requires Larger Print for Drug Labels

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.